Baseline81 wrote:MetalFingaz wrote:Is the marginal improvement worth the price? Should we limit minutes for Gravenberch or Bajectic to develop, potentially, into long-term solutions in the position or should we buy Barella or Koopmeiners (assuming either is actually available)? Should we spend $50m on someone who improves the midfield if that means we can't offer Trent the contract he wants and he walks for free to Madrid next year?
Gravenberch wasn't exactly a clean bill of health last season. And it sounds as if the club wants to loan Bajectic (RB Salzburg the rumor). I have always looked at Endo as a stop gap considering his age.
Yeah I don't see Endo getting a lot of starts in the league this year, barring injury.









